Subscribe To
Investor alert: abbott cooper pllc announces investigation into zentalis pharmaceuticals, inc.; urges zentalis stockholders to contact abbott cooper regarding their legal rights
STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” ...
November 4, 2023, 3:53 pm
Verona pharma plc (vrna) q3 2023 earnings call transcript
Verona pharma plc (NASDAQ:VRNA ) Q3 2023 Results Conference Call November 2, 2023 9:00 AM ET Company Pa...
November 4, 2023, 11:58 am
Chewy: pharmacy remains a big opportunity, but stock looks fairly valued
Chewy's autoship program is a major strength, with 75.5% of sales coming from autoship customers. The company has opportunities for growth in expandin...
November 4, 2023, 6:19 am
Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data
November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Therapeu...
November 3, 2023, 8:30 pm
Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting
– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...
November 3, 2023, 8:05 pm
Kineta reports third quarter 2023 financial results and provides corporate update
Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial Enrolled the first patient of KVA12123 in comb...
November 3, 2023, 8:01 pm
Actinium pharmaceuticals: the trickle down continues, and i maintain a buy
Actinium Pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, which has potential beyond market expectations. Th...
November 3, 2023, 6:08 pm
Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specia...
November 3, 2023, 12:41 pm
Galectin therapeutics to share five scientific presentations at the liver meeting™ 2023, hosted by the aasld
Pharmacokinetics and safety of belapectin in patients with hepatic insufficiency Lack of impact of belapectin on cardiac repolarization (QT interval) ...
November 3, 2023, 12:00 pm
Novo nordisk to release clinical update on star drug wegovy
Novo Nordisk (NYSE:NVO) remains firmly in favour with analysts at Barclays ahead of the latest trial data for diabetes drug Wegovy that is due next we...
November 3, 2023, 11:59 am
Cardinal health (cah) beats on q1 earnings, ups '24 eps view
Cardinal Health's (CAH) first-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance....
November 3, 2023, 11:18 am
Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage special...
November 3, 2023, 8:41 am
Astria therapeutics to present new star-0215 data at the 2023 american college of allergy, asthma, and immunology annual scientific meeting
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allerg...
November 3, 2023, 8:10 am
Why is altamira therapeutics (cyto) stock up 28% today?
Altamira Therapeutics (NASDAQ: CYTO ) stock is rising higher on Friday despite a lack of news from the biopharmaceutical company. There are no new pr...
November 3, 2023, 7:53 am
Cliff notes: a central bank trifecta
Key insights from the week that was. In Australia, nominal retail sales rose strongly in September, up 0.9% (2.0%yr). However, this was mostly due to ...
November 3, 2023, 5:22 am
Acadia pharmaceuticals inc. (acad) q3 2023 earnings call transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Jessica Tieszen - Associa...
November 3, 2023, 3:54 am
Poolbeg's lead asset to be in the spotlight at leading medical conference
Poolbeg pharma PLC (AIM:POLB, OTCQB:POLBF) said the potential of its lead asset will be discussed at a ...
November 3, 2023, 3:32 am
Apellis alert: bragar eagel & squire, p.c. is investigating apellis pharmaceuticals, inc. on behalf of long-term stockholders and encourages investors to contact the firm
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
November 3, 2023, 1:00 am
Coherus biosciences to participate at upcoming november investor conferences
REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that senior managemen...
November 3, 2023, 12:00 am
Ultragenyx pharmaceutical, inc. (rare) q3 2023 earnings call transcript
Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Joshua Higa - Vice Pr...
November 2, 2023, 10:29 pm